- Molecules
- 21
MedsAcross lists 21 molecules linked to Melanoma, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- TemozolomideOrphanAlkylating Drug13 presentations6 brandsL01AX03
- DocetaxelMicrotubule Inhibitor14 presentations6 brandsL01CD02
- PaclitaxelOrphanMicrotubule Inhibitor10 presentations8 brandsL01CD01
- HydroxyureaOrphanAntimetabolite10 presentations6 brandsL01XX05
- BevacizumabOrphanVascular Endothelial Growth Factor Inhibitor13 presentations17 brandsL01FG01
- LomustineAlkylating Drug6 presentations1 brandL01AD02
- BleomycinCytoprotective Agent2 presentationsL01DC01
- DactinomycinActinomycin2 presentationsL01DA01
- NivolumabOrphanProgrammed Death Receptor-1 Blocking Antibody4 presentations2 brandsL01FF01
- DacarbazineAlkylating Drug2 presentationsL01AX04
- DabrafenibOrphanKinase Inhibitor3 presentations3 brandsL01EC02
- EncorafenibOrphan1 presentation2 brandsL01EC03
- IpilimumabOrphanCTLA-4-directed Blocking Antibody2 presentations2 brandsL01FX04
- Talimogene laherparepvecBiologic2 presentations2 brandsL01XL02
- PembrolizumabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation1 brandL01FF02
- AldesleukinOrphanLymphocyte Growth Factor1 presentation1 brandL03AC01
- CobimetinibOrphanKinase Inhibitor1 presentation2 brandsL01EE02
- ProcarbazineAlkylating Drug1 presentation1 brandL01XB01
- SargramostimOrphanLeukocyte Growth Factor1 presentation2 brandsL03AA09
- VemurafenibOrphanKinase Inhibitor1 presentation2 brandsL01EC01
- TrametinibOrphan2 brandsL01EE01
Access for rare diseases
Medicines for rare diseases are often not registered in the patient's country. Named-patient and special access routes let a physician or hospital import them legally.
Orphan and rare disease medicinesFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Melanoma?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.